Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This Year

Updated Feb 8, 2022, 11:35am EST Topline Despite skyrocketing revenue from the sale of Covid-19 vaccines, shares of Pfizer plunged Tuesday morning after the pharmaceutical giant issued worse-than-expected revenue guidance for this year, triggering a widespread plunge among vaccine stocks that have struggled to meet analyst expectations as the pandemic begins to wane. Key Facts…
Read More